News | December 20, 2023
Asahi Kasei opens new Bioprocess Technical Center in China
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases
The €70 million investment will allow the large-scale manufacturing of high-purity reagents for quality control and testing for biopharma customers, increasing annual output by several thousand tons
This patent-pending, high-efficiency chromatography media is used for the purification of novel peptide-based pharmaceuticals in the GLP-1 agonist class including type 2 diabetes and obesity treatments
The new range of HDPE bottles is compliant with US FDA, EU regulations and Chinese DMF registration for use in dry pharmaceutical applications
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
Purchase agreement with ViewRay will make state-of-the art precision radiation therapy available in China
Subscribe To Our Newsletter & Stay Updated
